Gangwon-do, South Korea

Kyoung-Min Min


 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kyoung-Min Min: Innovator in Botulinum Toxin Production

Introduction

Kyoung-Min Min is a notable inventor based in Gangwon-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of botulinum toxin. With a total of 4 patents to his name, Min's work is recognized for its innovative approaches to enhancing bacterial culture methods.

Latest Patents

Kyoung-Min Min's latest patents focus on medium compositions for preparing botulinum toxin. One of his inventions relates to a medium composition that includes at least one plant-derived peptone, such as garden pea hydrolysate, cotton seed hydrolysate, and wheat gluten hydrolysate. This medium composition significantly increases the growth rate of the bacterium, achieving a rate that is approximately 1.5-2 times higher than current mediums. Additionally, this invention aims to prevent infections associated with transmissible spongiform encephalopathy (TSE) by eliminating animal-derived components from the culture medium. Another patent also emphasizes the use of porcine peptone alongside plant-derived peptones, resulting in a higher concentration of botulinum toxin produced in a safe manner.

Career Highlights

Kyoung-Min Min is currently employed at Daewoong Co., Ltd., where he continues to advance his research in biotechnology. His work has not only contributed to the scientific community but has also had practical applications in the medical field.

Collaborations

Min collaborates with talented coworkers, including Kyoung-Yun Kim and Hye-Young Sul, who contribute to his innovative projects and research endeavors.

Conclusion

Kyoung-Min Min is a prominent figure in the field of biotechnology, particularly known for his advancements in botulinum toxin production. His innovative patents and contributions to Daewoong Co., Ltd. highlight his commitment to enhancing bacterial culture methods and ensuring safety in toxin production.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…